EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sentinel Lymph Node Mapping in Endometrial Cancer: Experience from a Tertiary Referral Center in Türkiye

Eyüp Gökhan Turmuş iD, Okan Oktar iD, Hande Esra Koca Yildirim iD, Baran Yeşil iD, Mustafa Taze, Nigar Mammadova, İzzet Özgürlük, Çiğdem Kılıç, Burak Ersak, Caner Çakır iD

Journal of Clinical Medicine · 29.10.2026 · 15 (21) · 8410

DOI: 10.3390/jcm15218410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.10.2026. Verfasst von Eyüp Gökhan Turmuş und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sentinel lymph node (SLN) mapping has become an established alternative to systematic lymphadenectomy for surgical staging in endometrial cancer. This study evaluated SLN mapping rates, anatomical distribution, factors associated with mapping failure, and perioperative outcomes in patients with early-stage endometrial cancer.

Methods

This retrospective cohort study included patients with early-stage endometrial cancer who underwent SLN mapping during minimally invasive surgical staging between September 2022 and January 2025. Overall and bilateral SLN detection rates were calculated. Anatomical distribution of SLNs, factors associated with mapping failure (including a hemipelvis-level generalized estimating equation [GEE] analysis), and perioperative outcomes according to surgical approach were analyzed.

Results

A total of 165 patients were included. The overall SLN detection rate was 96.4%, and bilateral mapping was achieved in 125 patients (75.8%). A total of 584 SLNs were removed, most commonly from the iliac basin. In the hemipelvis-level GEE analysis (330 hemipelves, 46 failures), ICG use (adjusted odds ratio [OR] 4.50, 95% confidence interval [CI] 1.07–18.83) and, in a sensitivity model, conventional laparoscopy compared with robotic surgery (OR 2.31, 95% CI 1.14–4.69) were associated with higher odds of mapping failure, whereas age and BMI were not. Operative time and intraoperative complication rates were comparable among laparoscopic, robotic-assisted, and vaginal natural orifice transluminal endoscopic surgery (vNOTES) procedures. Postoperative complication rates and length of hospital stay differed significantly across surgical approaches (both p = 0.002); post hoc pairwise comparison of complication rates showed that the difference was driven mainly by conventional laparoscopy compared with robotic-assisted surgery, whereas the small vNOTES group (n = 8) did not differ significantly from either approach and does not permit conclusions on its comparative safety.

Conclusions

SLN mapping demonstrated high overall detection rates and acceptable bilateral mapping success in early-stage endometrial cancer. These findings support the feasibility of SLN mapping as a minimally invasive staging strategy in routine clinical practice.

Schlagwörter

Stichwörter der Autor:innen

endometrial cancerminimally invasive surgeryrobotic surgerysentinel lymph node mappingsurgical stagingvNOTES

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
  • Department of Gynecologic Oncology, Ministry of Health Ankara Training and Research Hospital, Ankara 06230, Türkiye.
  • Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara 06170, Türkiye.
  • Department of Gynecology and Obstetrics, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara 06800, Türkiye.

ORCID-Profile: Eyüp Gökhan Turmuş, Okan Oktar, Hande Esra Koca Yildirim, Baran Yeşil, Caner Çakır

Zitieren

APA

Turmuş, E. G., Oktar, O., Koca Yildirim, H. E., Yeşil, B., Taze, M., Mammadova, N., Özgürlük, İ., Kılıç, Ç., Ersak, B., & Çakır, C. (2026). Sentinel Lymph Node Mapping in Endometrial Cancer: Experience from a Tertiary Referral Center in Türkiye. Journal of Clinical Medicine, 15(21), 8410. https://doi.org/10.3390/jcm15218410

Vancouver

Turmuş EG, Oktar O, Koca Yildirim HE, Yeşil B, Taze M, Mammadova N, et al. Sentinel Lymph Node Mapping in Endometrial Cancer: Experience from a Tertiary Referral Center in Türkiye. Journal of Clinical Medicine. 2026;15(21):8410. doi:10.3390/jcm15218410

BibTeX
@article{Turmu2026,
  author = {Turmuş, Eyüp Gökhan and Oktar, Okan and Koca Yildirim, Hande Esra and Yeşil, Baran and Taze, Mustafa and Mammadova, Nigar and Özgürlük, İzzet and Kılıç, Çiğdem and Ersak, Burak and Çakır, Caner},
  title = {Sentinel Lymph Node Mapping in Endometrial Cancer: Experience from a Tertiary Referral Center in Türkiye},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8410},
  doi = {10.3390/jcm15218410}
}
Kostenlos starten →